Competitive intelligence on
small-molecule drugs and
the 80,000 global patents
covering them

Start your free trial now

No commitment — No credit card required

DrugPatentWatch Ultimate Plan Preview

Details for Generic Name: nicotine

« Back to Dashboard

Summary for Generic Name: nicotine

Tradenames:10
Patents:5
Applicants:12
NDAs:43
Drug Master File Entries: see list28
Suppliers: see list13
Therapeutic Class:Antidotes, Deterrents, and Toxicologic Agents

Pharmacology for Ingredient: nicotine

Ingredient-typeNicotine
Drug ClassCholinergic Nicotinic Agonist

Clinical Trials for: nicotine

Pilot Pharmacokinetic Study of Investigational Sublingual Nicotine Tablet Versus COMMIT Nicotine Lozenge
Status: Recruiting Condition: Nicotine Pharmacokinetic Study

Comparison of Pharmacokinetic Profiles of Two Nicotine Gum Formulations
Status: Completed Condition: Smoking Cessation

Single-dose Nicotine Pharmacokinetics With a New Oral Nicotine Replacement Product
Status: Completed Condition: Tobacco Dependence

Nicotine Vaccination and Nicotinic Receptor Occupancy
Status: Completed Condition: Nicotine Dependence

Multiple-dose Nicotine Pharmacokinetics With a New Oral Nicotine Replacement Product.
Status: Completed Condition: Tobacco Dependence

Neural Mechanisms Underlying Nicotine and Alcohol Combinations
Status: Recruiting Condition: Focus: Effects of Nicotine and Alcohol on Brain Circuits

Nicotine Dependence, Withdrawal and Replacement Therapy Assessed by PET Imaging
Status: Recruiting Condition: Nicotine Dependence

Reduced Nicotine Content Cigarettes in Smokers of Lower Socioeconomic Status
Status: Not yet recruiting Condition: Tobacco Dependence

Nicotine Lozenge Bioequivalence Study
Status: Completed Condition: Smoking Cessation

Reduced Nicotine Cigarettes in Smokers With Mood and Anxiety Disorders
Status: Not yet recruiting Condition: Tobacco Dependence

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline Cons
NICORETTE
nicotine polacrilex
TROCHE/LOZENGE;ORAL022360May 18, 2009OTCYes8,501,164<disabled>Y<disabled>
Watson Labs
NICOTINE POLACRILEX
nicotine polacrilex
GUM, CHEWING;BUCCAL079038Jul 8, 2009OTCNo<disabled><disabled>
Glaxosmithkline
NICORETTE
nicotine polacrilex
GUM, CHEWING;BUCCAL018612Feb 9, 1996OTCYes8,323,683<disabled><disabled>
Aveva
NICOTINE
nicotine
FILM, EXTENDED RELEASE;TRANSDERMAL074612Oct 20, 1997OTCNo<disabled><disabled>
Novartis
THRIVE
nicotine polacrilex
GUM, CHEWING;BUCCAL077658Jun 19, 2007OTCNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access , or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013  

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: PatentStatBiotechBlogJournal of Commercial Biotechnology

`abc